Compound Detail
CHEMBL298991
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL298991 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DTVHTYSDFKSFIJ-UHFFFAOYSA-N |
2
Targets
4
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
388.6
MW (Da)
3.50
ALogP
7
HBA
2
HBD
85.1
PSA (Ų)
0.50
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.3
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HeLa | IC50 | = | 5000.0 | nM | 5.3 | Inhibition of HSV-1 DNA synthesis in virus-infected HeLa cells | 7752206 |
| HeLa | IC50 | = | 7400.0 | nM | 5.13 | Inhibition of [3H]thymidine incorporation into the DNA of uninfected HeLa cells | 7752206 |
| HEL | IC50 | = | 12500.0 | nM | 4.9 | Inhibition of human CMV DNA synthesis in CMV-infected HEL cells. | 7752205 |
| HEL | IC50 | = | 14400.0 | nM | 4.84 | Inhibition against DNA of uninfected HEL cells by incorporation of [3H]TdR. | 7752205 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7752205 | 10.1021/jm00010a026 | HEL | 2 |
| 7752206 | 10.1021/jm00010a027 | HeLa | 2 |
Data from ChEMBL 36 via Core Engine